VAC2VAC
| Knowledge Source Identification | |
|---|---|
| Knowledge source name | VAC2VAC |
| Owner/Developer | Innovative Medicines Initiative |
| Abbreviated owner | IMI |
| Country | Germany |
| Languages | English |
| URL | http://www.euvaccine.eu/sites/default/files/uploads/docs/news/VAC2VAC_PR_final_160614.pdf |
| Contact email | contact.us@euvaccine.eu |
| Description | VAC2VAC is a wide-ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods. The initiative that started on 1 March 2016 aims to provide the data to support the ‘Consistency Approach’ for quality control of established vaccines. The current quality control approach for final products relies on in vivo methods. |
| Knowledge Source Category | |
| Category | Research Program/Project/Grant |
| Sub categories | EU Program |
| Knowledge Dissemination and Sharing | |
| Dissemination channel | Website |
| Targeted audience (specified/objective analysis) | Industry |
| Users access | Open access |
| Knowledge Characterization | |
| 3Rs relevance | Replacement, Reduction |
| Purpose | Validation, Method development |
| Legislative framework | Medicines legislation |